Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00468988 · ClinicalTrials.gov registry record · Phase 4
Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers
A Phase 4 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00468988 is a Phase 4 study that has completed, run by Alcon Research. The registered enrollment target is 30 participants.
The verdict
NCT00468988, a Phase 4 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
Compare the effect of Xalatan with benzalkonium chloride on the ocular surface to those effects observed with Travatan Z without benzalkonium chloride after a single dose
Interventions
- DRUG Travatan® Z
- DRUG Xalatan®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-05 |
| Est. Completion | 2007-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00468988
The ClinicalTrials.gov registry entry for NCT00468988 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Travatan® Z is the first listed.
NCT00468988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00468988 about?
NCT00468988 is a clinical study titled "Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers". Compare the effect of Xalatan with benzalkonium chloride on the ocular surface to those effects observed with Travatan Z without benzalkonium chloride after a single dose
What is the current status of trial NCT00468988?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2007-05. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00468988?
The interventions under investigation include: Travatan® Z (DRUG), Xalatan® (DRUG).
Who is sponsoring clinical trial NCT00468988?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.